Showing results (1691-1700 of 1,722) with videos related to
Sort By:
Pageof 173
Cancer Discovery|November 8, 2011
An LXR agonist promotes glioblastoma cell death through inhibition of an EGFR/AKT/SREBP-1/LDLR-dependent pathwayDeliang Guo, Felicia Reinitz, Mary Youssef, et al.Cell Genomics|June 30, 2023
A systems biology approach uncovers novel disease mechanisms in age-related macular degenerationLuz D Orozco, Leah A Owen, Jeffrey Hofmann, et al.Nature|January 25, 2019
Tracking tumour evolution in glioma through liquid biopsies of cerebrospinal fluidAlexandra M Miller, Ronak H Shah, Elena I Pentsova, et al.Journal of the National Comprehensive Cancer Network : JNCCN|September 14, 2013
Central nervous system cancersLouis Burt Nabors, Mario Ammirati, Philip J Bierman, et al.Journal of Hematology & Oncology|August 22, 2020
Daratumumab, bortezomib, and dexamethasone in relapsed or refractory multiple myeloma: subgroup analysis of CASTOR based on cytogenetic riskKatja Weisel, Andrew Spencer, Suzanne Lentzsch, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 18, 2006
Phase I/II study of imatinib mesylate for recurrent malignant gliomas: North American Brain Tumor Consortium Study 99-08Patrick Y Wen, W K Alfred Yung, Kathleen R Lamborn, et al.Neuro-Oncology|June 4, 2011
International retrospective study of over 1000 adults with anaplastic oligodendroglial tumorsAndrew B Lassman, Fabio M Iwamoto, Timothy F Cloughesy, et al.Neuro-Oncology|June 5, 2012
Initial treatment patterns over time for anaplastic oligodendroglial tumorsKatherine S Panageas, Fabio M Iwamoto, Timothy F Cloughesy, et al.Journal of the National Comprehensive Cancer Network : JNCCN|November 2, 2014
Central nervous system cancers, version 2.2014. Featured updates to the NCCN GuidelinesLouis Burt Nabors, Jana Portnow, Mario Ammirati, et al.World Journal of Emergency Surgery : WJES|April 2, 2020
Liver trauma: WSES 2020 guidelinesFederico Coccolini, Raul Coimbra, Carlos Ordonez, et al.Pageof 173